Josep Tabernero Caturla-rekin lankidetzan egindako argitalpenak (4)

2015

  1. Patterns of HER2 gene amplification and response to anti-HER2 therapies

    PLoS ONE, Vol. 10, Núm. 6

2007

  1. Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast cancer

    Journal of Clinical Oncology, Vol. 25, Núm. 23, pp. 3399-3406

2005

  1. Phase II and tumor pharmacodynamic study of gefitinib in patients with advanced breast cancer

    Journal of Clinical Oncology, Vol. 23, Núm. 23, pp. 5323-5333

2004

  1. A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer

    Annals of Oncology, Vol. 15, Núm. 9, pp. 1358-1365